Dow Today: E.I. Du Pont De Nemours & Company (DD) Lower

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

The Dow Jones Industrial Average ( ^DJI) is trading up 33 points (+0.2%) at 15,028 as of Thursday, Jun 13, 2013, 10:35 a.m. ET. During this time, 119 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 600.1 million. The NYSE advances/declines ratio sits at 1,570 issues advancing vs. 1,306 declining with 109 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is E.I. du Pont de Nemours & Company (NYSE: DD), which is lagging the broader Dow index with a 31-cent decline (-0.6%) bringing the stock to $53.92. Volume for E.I. du Pont de Nemours & Company currently sits at 2.4 million shares traded vs. an average daily trading volume of 6.6 million shares.

E.I. du Pont de Nemours & Company has a market cap of $50.49 billion and is part of the basic materials sector and chemicals industry. Shares are up 20.6% year to date as of Wednesday's close. The stock's dividend yield sits at 3.3%.

E. I. du Pont de Nemours and Company operates as a science and technology based company worldwide. Its Agriculture segment provides corn hybrid, soybean, canola, sunflower, sorghum, inoculants, wheat, and rice seed products under the Pioneer brand; and herbicides, fungicides, and insecticides. The company has a P/E ratio of 21.1, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates E.I. du Pont de Nemours & Company as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more..
null

If you liked this article you might like

Why Bayer's $66 Billion Takeover of Monsanto Probably Won't Happen Until 2018

DowDupont Closes Higher in First Day of Trading, Company Still Faces Challenges

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

FMC Stock's Impressive Rally Has Another 20% to Gain: Jim Cramer

Jim Cramer on Why FMC Was Upgraded by Bank of America